Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |